Search Result "risankizumab"
Novel Therapeutic Approaches and Targets for Treatment of Psoriasis
Journal: Current Pharmaceutical Biotechnology
Volume: 22 Issue: 1 Year: 2021 Page: 7-31
Author(s): Giulia Radi,Anna Campanati,Federico Diotallevi,Tommaso Bianchelli,Annamaria Offidani
An Overview of Contemporary and Future Therapeutic Strategies forScalp Psoriasis
Journal: Current Drug Targets
Volume: 25 Issue: 5 Year: 2024 Page: 353-373
Author(s): Subheet Kumar Jain
Role of Angiogenic Growth Factors in Psoriasis: A Review
Journal: Current Drug Metabolism
Volume: 19 Issue: 1 Year: 2018 Page: 910-916
Author(s): Tahseena Akhtar,Willayat Yousuf Wani,Mohammad Amjad Kamal,Rajinder Kaur
Challenges in Immunomodulation for Psoriasis: Recent Advancements andNeed of Therapies
Journal: Current Drug Therapy
Volume: 19 Issue: 3 Year: 2024 Page: 275-278
Author(s):
Recent Advancements in Novel Formulations of Anti-psoriatic Agents forEffective Delivery: Clinical Importance and Patent Survey
Journal: Recent Patents on Nanotechnology
Volume: 18 Issue: 3 Year: 2024 Page: 259-277
Author(s): Balak Das Kurmi
Monoclonal Antibodies as Therapeutic Agents for Inflammatory Diseases
Ebook: Frontiers in Clinical Drug Research: Anti-Infectives
Volume: 8 Year: 2021
Author(s): Mara G. Freire,Ana P.M. Tavares,Emanuel V. Capela,Jéssica Bairos
Doi: 10.2174/9789815039412121080003
The Risk of Opportunistic Infections in Patients with InflammatoryBowel Disease
Journal: The International Journal of Gastroenterology and Hepatology Diseases
Volume: 1 Issue: 1 Year: 2022 Page: 11-18
Author(s):
Systemic Treatments for Adult Patients with Moderate-to-Severe Psoriasis:Consensus Statements for the United Arab Emirates
Journal: New Emirates Medical Journal
Volume: 3 Issue: 1 Year: 2022 Page: 17-34
Author(s): Anwar Al Hammadi,Muna Al Murrawi,Huda R. Ali,Ashraf M. Reda,Hussein A. Dayem,Jawaher Alnaqbi,Zaidoon Abdelhadi,Samir Hantirah,Ayman Alnaeem,Fatima Al. Marzooqi,Amani Alfalasi,Fatima Albreiki,Khadija Aljefri,Faiza Al Ali
Interleukin-23 Blockers: Born to be First-line Biologic Agents in Inflammatory Bowel Disease?
Journal: Current Pharmaceutical Design
Volume: 25 Issue: 1 Year: 2019 Page: 25-31
Author(s): Marjorie C. Argollo,Mariangela Allocca,Federica Furfaro,Laurent Peyrin-Biroulet,Silvio Danese
Neutrophilic Asthma and Potentially Related Target Therapies
Journal: Current Drug Targets
Volume: 21 Issue: 4 Year: 2020 Page: 374-388
Author(s): Pranav Nair,Kedar S. Prabhavalkar